Terms ending in 2034
Every in-force patent on Ariosa Diagnostics, Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,031,095 | Assay Systems for Determination of Fetal Copy Number Variation In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 12,744,106 | Processes for Calculating Phased Fetal Genomic Sequences In force · High confidence | Ariosa Diagnostics, Inc. | In force | High confidence | |
| US 9,206,417 | Multiplexed Sequential Ligation-Based Detection of Genetic Variants In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 11,441,185 | Noninvasive Detection of Fetal Aneuploidy in Egg Donor Pregnancies In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 11,404,142 | Processes for Calculating Phased Fetal Genomic Sequences In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 10,131,947 | Noninvasive Detection of Fetal Aneuploidy in Egg Donor Pregnancies In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 10,718,019 | Risk Calculation for Evaluation of Fetal Aneuploidy In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 11,270,781 | Statistical Analysis for Non-Invasive Sex Chromosome Aneuploidy Determination In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence | |
| US 12,195,799 | Risk Calculation for Evaluation of Fetal Aneuploidy In force · High confidence | Roche Molecular Systems, Inc. | In force | High confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Ariosa Diagnostics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.